Business
TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 29th Annual Meeting
WALTHAM, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer, today announced the acceptance of an abstract for poster presentation at the upcoming American Society of Gene and Cell Therapy (ASGCT) 29ᵗʰ Annual Meeting being held May 11 – 15 in Boston, MA as well as virtually. Poster Presentation Det
About this update from Tscan Therapeutics, Inc.
[{"type":"image","alt":"TScan Therapeutics, Inc.","displaySize":"","headline":null,"caption":"TScan Therapeutics, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":88,"url":"https://media.zenfs.com/en/globenewswire.com/c363c98946cf506a90ed1ea98d7db5fd"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/YfLE.tTPxOAW9VIQ82xcYA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEyMw--/https://media.zenfs.com/en/globenewswire.com/c363c98946cf506a90ed1ea98d7db5fd","width":300,"height":88}},"lazy":false},{"type":"text","content":"WALTHAM, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer, today announced the acceptance of an abstract for poster presentation at the upcoming American Society of Gene and Cell Therapy (ASGCT) 29ᵗʰ Annual Meeting being held May 11 – 15 in Boston, MA as well as virtually.","length":476,"tagName":"p"},{"type":"text","content":"Poster Presentation Details:","length":28,"tagName":"p"},{"type":"text","content":"Title: Novel CD45-targeted TCR-T cell therapies designed to eliminate residual disease and prevent relapse following allogeneic hematopoietic cell transplantation Authors: Hannah L Bader, Kostadin P Petrov, Stephen Carroll, Debanjan Goswamy, Nivya Sharma, Shubhangi Kamalia, Daniel Pollacksmith, Drashti Sha, Kenneth L Jahan, Ryan E Kritzer, Hana Husic, Shobhita Jillella, Nicole Ladd, Jackson Lirette, Shoshana Bloom, Prachi Dhanania, Lisa Fleischer, Chandan K Pavuluri, Tyler M Sinacola, Savannah G Szemethy, McKenna A Merrill, Kyra N Sur, Carolyn Hardy, Zhonghua Zhu, Elisaveta Todorova, Alexander Cristofaro, Livio Dukaj, Kimberly M Cirelli, Antoine Boudot, Mollie M Jurewicz, Cagan GurerAbstract ID: 1256Session Date/Time: Tuesday, May 12; Poster Reception: 5:00 - 6:30 p.m. Eastern TimeLocation: Poster Hall, Thomas M. Menino Convention & Exhibition Center","length":895,"tagName":"p"},{"type":"text","content":"Once the presentation has concluded, a copy of the materials will be added to the “Publications” section of the Company’s website at tscan.com.","length":143,"tagName":"p"},{"type":"text","content":"About TScan Therapeutics, Inc.","length":30,"tagName":"p"},{"type":"text","cont...